Chest Medicine
[Abstract Only] A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention
4 Jun, 2020 | 04:47h | UTC
Coronavirus: What a Second Wave Might Look Like
3 Jun, 2020 | 04:01h | UTCCoronavirus: what a second wave might look like – The Conversation
Video: Coronavirus Q&A with Anthony Fauci, MD
3 Jun, 2020 | 04:02h | UTCCoronavirus Q&A with Anthony Fauci, MD – JAMA
Blood Vessel Attack Could Trigger Coronavirus’ Fatal ‘Second Phase’
3 Jun, 2020 | 03:56h | UTCBlood vessel attack could trigger coronavirus’ fatal ‘second phase’ – Science
[Preprint] Superspreaders: 20% of Covid-19 Cases are Responsible for 80% of Local Transmission
3 Jun, 2020 | 03:59h | UTCCommentary: Just Stop the Superspreading – The New York Times
Related: Why do some COVID-19 patients infect many others, whereas most don’t spread the virus at all? – Science AND ‘Superspreaders’ Could Actually Make Covid-19 Easier to Control – Bloomberg
Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill Patients with COVID-19
3 Jun, 2020 | 03:44h | UTC
Meta-Analysis: Physical Distancing, Face Masks, and Eye Protection to Prevent Transmission of COVID-19
2 Jun, 2020 | 05:12h | UTCCommentaries: Most comprehensive study to date provides evidence on optimal physical distancing, face masks, and eye protection to prevent spread of COVID-19 – The Lancet AND Physical distancing, face masks, and eye protection for prevention of COVID-19 – The Lancet AND Medical Workers Should Use Respirator Masks, Not Surgical Masks – The New York Times AND Expert reaction to review of optimal physical distancing, face masks, and eye protection to prevent spread of COVID-19 – Science Media Centre AND Evidence supports physical distancing, masks, and eye protection to help prevent COVID-19 – McMaster University AND Social distancing and masks reduce risk of getting Covid-19, review finds – CNN
Remdesivir Shows Modest Improvement in Moderate COVID-19 Patients
2 Jun, 2020 | 04:59h | UTC- Gilead’s remdesivir shows modest improvement in moderate COVID-19 patients – Reuters
- Expert reaction to press release announcing results of stage 3 trial of Gilead’s antiviral remdesivir in moderate patients – Science Media Centre
- Gilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show – STAT
CT in Covid-19: A Systematic Review of Chest CT Findings
2 Jun, 2020 | 04:56h | UTC
[Abstract Only] Obstructive Sleep Apnea Treatment and Blood Pressure: Which Phenotypes Predict a Response?
2 Jun, 2020 | 04:47h | UTC
Cohort Study: Mortality and Pulmonary Complications in Surgical Patients with Covid-19
1 Jun, 2020 | 04:02h | UTCCommentaries: Mitigating the risks of surgery during the COVID-19 pandemic – The Lancet AND COVID-19 patients who undergo surgery are at increased risk of postoperative death – University of Birmingham AND Clinicians must carefully balance risk of complications linked to SARS-CoV2 infection with risks of delaying surgery – The Lancet
Observational Study: Many Patients with Covid-19 in the ICU Develop Thromboembolism Despite Routine Prophylaxis
29 May, 2020 | 03:17h | UTC
WHO Interim Guidance: Clinical Management of COVID-19
28 May, 2020 | 10:02h | UTCClinical management of COVID-19 – World Health Organization
Face Coverings for the Public: Laying Straw Men to Rest, by Trisha Greenhalgh
28 May, 2020 | 09:57h | UTCFace coverings for the public: Laying straw men to rest – Journal of Evaluation in Clinical Practice
Related: Face coverings for the lay public: an alternative view – CEBM Oxford AND Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach – Annals of Internal Medicine
https://twitter.com/EricTopol/status/1265640531016552449
Systematic Review: Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19
28 May, 2020 | 09:59h | UTC
Perspective: Reducing Transmission of SARS-CoV-2
28 May, 2020 | 09:55h | UTCReducing transmission of SARS-CoV-2 – Science
Remdesivir for Covid-19: A 5-day Course is Similarly Effective as a 10-day Course
28 May, 2020 | 10:00h | UTCRemdesivir for 5 or 10 Days in Patients with Severe Covid-19 – New England Journal of Medicine
Study: Loss of Smell and Taste in 2013 Patients with Mild to Moderate COVID-19
27 May, 2020 | 02:35h | UTC
CDC Updated Guidance: When You Can be Around Others After You Had or Likely Had COVID-19
27 May, 2020 | 02:37h | UTC“I think or know I had COVID-19, and I had symptoms.”
You can be with others after:
- 3 days with no fever AND
- Symptoms improved AND
- 10 days since symptoms first appeared”
Clinical Guidance: Advanced Pulmonary and Cardiac Support of COVID-19 Patients
27 May, 2020 | 02:27h | UTC
Just the Facts: What Drugs are Safe and Effective for COVID-19?
27 May, 2020 | 02:31h | UTCRelated Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection
“Apart from supportive care, there are no current effective therapeutics for COVID-19”
A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2
27 May, 2020 | 02:22h | UTCA Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2 – The FEBS Journal
Duration of Prone Position Sessions: A Prospective Cohort Study
27 May, 2020 | 02:20h | UTCDuration of prone position sessions: a prospective cohort study – Annals of Intensive Care
Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19
27 May, 2020 | 02:21h | UTC
Podcast: Evidence-Based Medicine for the Management of COVID-19 ARDS
26 May, 2020 | 09:57h | UTCRelated Perspective from the Author: In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS – Annals of the American Thoracic Society